openPR Logo
Press release

Osteoarthritis Market 2023 Top Players | Novartis AG, ABIOGEN PHARMA S.p.A, TissueGene Inc, Ampio Pharmaceuticals Inc and More

03-21-2018 08:15 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Osteoarthritis Market 2023 Top Players | Novartis AG, ABIOGEN

Osteoarthritis is a type of arthritis that occurs when flexible tissue at the ends of bones wears down. Increasing age is the major factor for the cause of the disease. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently forecasted in its report on Global Osteoarthritis Market Research Report- Forecast to 2023 that the market will demonstrate a steady CAGR while achieving million dollar growth readily in the forecast period.

The Global Osteoarthritis Market is expected to grow at an approximate CAGR of 6.8% during the forecast period 2018-2023.

Osteoarthritis is the most common form of arthritis which generally affects the hands, knee, hip and spines. It can causes pain, swelling, and reduced motion in the joints. Geriatric population and over-weighted individuals are at higher risks of osteoarthritis. Factors like growing geriatric population, rising prevalence of the osteoarthritis and increasing per capita healthcare expenditure will drive the market growth during the forecast period. In 2015, according to the National Institutes of Health, the American geriatric population is expected to nearly double from 48 million in 2015 to 88 million by 2050. Moreover, in 2015, according to the Centres for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, low per capita income in the developing countries and side effects of the treatment procedures will restrain the market growth during the forecast period

Owing to the increasing number of the people suffering from osteoarthritis many companies are involved in the manufacturing and introduction of the better and effective treatment and diagnostic options. A number of diagnostic treatment such as imaging (X-rays, magnetic resonance imaging (MRI), and bone scan), joint fluid analysis and others are available. However these are not that effective thus, many private and government organizations are providing support to the manufacturer for the development of the new and advanced devices.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/1609 .

Competitive Analysis:

A number of industries are working in the development and production of osteoarthritis products. It is found out that the market players have adopted the organic strategy of development of better and cost-effective products, and acquisition. The companies are aiming to capture a considerable share of the market segment as early as possible, due to continuously increasing competition. In order to gain the customer attention the companies have launched innovate products.

The key players profiled in osteoarthritis are Abbott. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), Eli Lilly and Company. (U.S.), ABIOGEN PHARMA S.p.A (Europe), Merck Sharp & Dohme Corp. (U.S.), TissueGene Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.), and others.

Latest Industry Updates:

Being a competitive market, a number of different manufacturer are focusing on the product launch, and acquisition for the market development. Some of the latest development in the market are-

May 2017 Ablynx, a biopharmaceutical company headquartered in Belgium, announced the completion of a preclinical package for a novel nanobody, ALX-1141 for the treatment of the osteoarthritis. Merck will now be responsible for further clinical development of the molecule.

Jul 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea.

Aug 2016, Bioventus, a global leader in orthobiologic solutions launched GELSYN-3, a three-injection hyaluronic acid (HA) product for pain relief associated with osteoarthritis (OA) of the knee.

Segmentation:

The global osteoarthritis market is segmented on the basis of type, diagnosis, treatment, and end users.

On the basis of type, the market is segmented into hip osteoarthritis, wrist osteoarthritis, spinal osteoarthritis, and others.

On the basis of diagnosis, the market is segmented into imaging, joint fluid analysis, and others. The imaging segment, is sub segmented into X-rays, magnetic resonance imaging (MRI), and others.

Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1609 .

On the basis of treatment, the market is segmented into medication, surgery, therapy, and others. The medication segmented is sub segmented into analgesics and non-steroidal anti-inflammatory drugs, and others. The analgesics sub segment, by medication, is further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub segment, by medication, is further segmented into aspirin, ibuprofen, naproxen sodium and naproxen, and others.

On the basis of end users, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoarthritis Market 2023 Top Players | Novartis AG, ABIOGEN PHARMA S.p.A, TissueGene Inc, Ampio Pharmaceuticals Inc and More here

News-ID: 986501 • Views:

More Releases from Market Research Future

Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plastics, UltrePET, Biocirculo
Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plasti …
Global Americas Recycled Plastics Market Report from Market Research Forecast highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. What the Osteoarthritis Therapeutics Market Looks Like? The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8
Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by …
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369 North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a
Osteoarthritis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint
Osteoarthritis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries
Osteoarthritis-Pipeline by Review H2 2017
ReportsWeb.com has announced the addition of the “Osteoarthritis-Pipeline Review H2 2017” this report provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries